IBDEI02G ; ; 20-FEB-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 20, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2759,0)
 ;;=J9360^^30^223^36^^^^1
 ;;^UTILITY(U,$J,358.3,2759,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2759,1,1,0)
 ;;=1^J9360
 ;;^UTILITY(U,$J,358.3,2759,1,3,0)
 ;;=3^Vinblastine Sulfate (Velban) 1mg
 ;;^UTILITY(U,$J,358.3,2760,0)
 ;;=J9370^^30^223^37^^^^1
 ;;^UTILITY(U,$J,358.3,2760,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2760,1,1,0)
 ;;=1^J9370
 ;;^UTILITY(U,$J,358.3,2760,1,3,0)
 ;;=3^Vincristine Sulfate(VCR) 1mg
 ;;^UTILITY(U,$J,358.3,2761,0)
 ;;=J9390^^30^223^32^^^^1
 ;;^UTILITY(U,$J,358.3,2761,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2761,1,1,0)
 ;;=1^J9390
 ;;^UTILITY(U,$J,358.3,2761,1,3,0)
 ;;=3^Navelbine 10mgs
 ;;^UTILITY(U,$J,358.3,2762,0)
 ;;=J9001^^30^223^16^^^^1
 ;;^UTILITY(U,$J,358.3,2762,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2762,1,1,0)
 ;;=1^J9001
 ;;^UTILITY(U,$J,358.3,2762,1,3,0)
 ;;=3^Doxorubicin,liposome,10mg
 ;;^UTILITY(U,$J,358.3,2763,0)
 ;;=J9171^^30^223^14^^^^1
 ;;^UTILITY(U,$J,358.3,2763,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2763,1,1,0)
 ;;=1^J9171
 ;;^UTILITY(U,$J,358.3,2763,1,3,0)
 ;;=3^Docetaxel 1 mg
 ;;^UTILITY(U,$J,358.3,2764,0)
 ;;=J9070^^30^223^11^^^^1
 ;;^UTILITY(U,$J,358.3,2764,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2764,1,1,0)
 ;;=1^J9070
 ;;^UTILITY(U,$J,358.3,2764,1,3,0)
 ;;=3^Cyclophosphamide 100mg Inj
 ;;^UTILITY(U,$J,358.3,2765,0)
 ;;=J9351^^30^223^35^^^^1
 ;;^UTILITY(U,$J,358.3,2765,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2765,1,1,0)
 ;;=1^J9351
 ;;^UTILITY(U,$J,358.3,2765,1,3,0)
 ;;=3^Topotecan 0.1mg
 ;;^UTILITY(U,$J,358.3,2766,0)
 ;;=J9035^^30^223^3^^^^1
 ;;^UTILITY(U,$J,358.3,2766,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2766,1,1,0)
 ;;=1^J9035
 ;;^UTILITY(U,$J,358.3,2766,1,3,0)
 ;;=3^Bevacizumab Inj,10mg
 ;;^UTILITY(U,$J,358.3,2767,0)
 ;;=J9041^^30^223^5^^^^1
 ;;^UTILITY(U,$J,358.3,2767,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2767,1,1,0)
 ;;=1^J9041
 ;;^UTILITY(U,$J,358.3,2767,1,3,0)
 ;;=3^Bortezomib Inj, 0.1mg
 ;;^UTILITY(U,$J,358.3,2768,0)
 ;;=J9045^^30^223^8^^^^1
 ;;^UTILITY(U,$J,358.3,2768,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2768,1,1,0)
 ;;=1^J9045
 ;;^UTILITY(U,$J,358.3,2768,1,3,0)
 ;;=3^Carboplatin Inj, 50mg
 ;;^UTILITY(U,$J,358.3,2769,0)
 ;;=J9055^^30^223^9^^^^1
 ;;^UTILITY(U,$J,358.3,2769,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2769,1,1,0)
 ;;=1^J9055
 ;;^UTILITY(U,$J,358.3,2769,1,3,0)
 ;;=3^Cetuximab Inj, 10mg
 ;;^UTILITY(U,$J,358.3,2770,0)
 ;;=J8530^^30^223^12^^^^1
 ;;^UTILITY(U,$J,358.3,2770,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2770,1,1,0)
 ;;=1^J8530
 ;;^UTILITY(U,$J,358.3,2770,1,3,0)
 ;;=3^Cyclophosphamide Oral, 25mg
 ;;^UTILITY(U,$J,358.3,2771,0)
 ;;=J9206^^30^223^25^^^^1
 ;;^UTILITY(U,$J,358.3,2771,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2771,1,1,0)
 ;;=1^J9206
 ;;^UTILITY(U,$J,358.3,2771,1,3,0)
 ;;=3^Irinotecan Inj, 20mg
 ;;^UTILITY(U,$J,358.3,2772,0)
 ;;=J0135^^30^223^1^^^^1
 ;;^UTILITY(U,$J,358.3,2772,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2772,1,1,0)
 ;;=1^J0135
 ;;^UTILITY(U,$J,358.3,2772,1,3,0)
 ;;=3^Adalimumab Inj 20mg
 ;;^UTILITY(U,$J,358.3,2773,0)
 ;;=P9010^^30^224^22^^^^1
 ;;^UTILITY(U,$J,358.3,2773,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2773,1,1,0)
 ;;=1^P9010
 ;;^UTILITY(U,$J,358.3,2773,1,3,0)
 ;;=3^Whole Blood,Ea Unit
 ;;^UTILITY(U,$J,358.3,2774,0)
 ;;=P9012^^30^224^4^^^^1
 ;;^UTILITY(U,$J,358.3,2774,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2774,1,1,0)
 ;;=1^P9012
 ;;^UTILITY(U,$J,358.3,2774,1,3,0)
 ;;=3^Cryoprecipitate,Ea Unit
 ;;^UTILITY(U,$J,358.3,2775,0)
 ;;=P9016^^30^224^18^^^^1
 ;;^UTILITY(U,$J,358.3,2775,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2775,1,1,0)
 ;;=1^P9016
 ;;^UTILITY(U,$J,358.3,2775,1,3,0)
 ;;=3^RBC Leukocytes Reduced
 ;;^UTILITY(U,$J,358.3,2776,0)
 ;;=P9017^^30^224^6^^^^1
 ;;^UTILITY(U,$J,358.3,2776,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2776,1,1,0)
 ;;=1^P9017
 ;;^UTILITY(U,$J,358.3,2776,1,3,0)
 ;;=3^Plasma 1 Donor Frz w/in 8hrs
 ;;^UTILITY(U,$J,358.3,2777,0)
 ;;=P9019^^30^224^10^^^^1
 ;;^UTILITY(U,$J,358.3,2777,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2777,1,1,0)
 ;;=1^P9019
 ;;^UTILITY(U,$J,358.3,2777,1,3,0)
 ;;=3^Platelets,Ea Unit
 ;;^UTILITY(U,$J,358.3,2778,0)
 ;;=P9021^^30^224^20^^^^1
 ;;^UTILITY(U,$J,358.3,2778,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2778,1,1,0)
 ;;=1^P9021
 ;;^UTILITY(U,$J,358.3,2778,1,3,0)
 ;;=3^Red Blood Cells,Ea Unit
 ;;^UTILITY(U,$J,358.3,2779,0)
 ;;=P9022^^30^224^21^^^^1
 ;;^UTILITY(U,$J,358.3,2779,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2779,1,1,0)
 ;;=1^P9022
 ;;^UTILITY(U,$J,358.3,2779,1,3,0)
 ;;=3^Washed Red Blood Cells,Ea Unit
 ;;^UTILITY(U,$J,358.3,2780,0)
 ;;=P9023^^30^224^5^^^^1
 ;;^UTILITY(U,$J,358.3,2780,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2780,1,1,0)
 ;;=1^P9023
 ;;^UTILITY(U,$J,358.3,2780,1,3,0)
 ;;=3^Frozen Plasma,Pooled,SD
 ;;^UTILITY(U,$J,358.3,2781,0)
 ;;=P9034^^30^224^12^^^^1
 ;;^UTILITY(U,$J,358.3,2781,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2781,1,1,0)
 ;;=1^P9034
 ;;^UTILITY(U,$J,358.3,2781,1,3,0)
 ;;=3^Platelets,Pheresis
 ;;^UTILITY(U,$J,358.3,2782,0)
 ;;=P9035^^30^224^8^^^^1
 ;;^UTILITY(U,$J,358.3,2782,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2782,1,1,0)
 ;;=1^P9035
 ;;^UTILITY(U,$J,358.3,2782,1,3,0)
 ;;=3^Platelet Pheres Leuko Reduced
 ;;^UTILITY(U,$J,358.3,2783,0)
 ;;=P9036^^30^224^9^^^^1
 ;;^UTILITY(U,$J,358.3,2783,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2783,1,1,0)
 ;;=1^P9036
 ;;^UTILITY(U,$J,358.3,2783,1,3,0)
 ;;=3^Platelet Pheres Leukoredu Irrad
 ;;^UTILITY(U,$J,358.3,2784,0)
 ;;=P9038^^30^224^16^^^^1
 ;;^UTILITY(U,$J,358.3,2784,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2784,1,1,0)
 ;;=1^P9038
 ;;^UTILITY(U,$J,358.3,2784,1,3,0)
 ;;=3^RBC Irradiated
 ;;^UTILITY(U,$J,358.3,2785,0)
 ;;=P9039^^30^224^15^^^^1
 ;;^UTILITY(U,$J,358.3,2785,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2785,1,1,0)
 ;;=1^P9039
 ;;^UTILITY(U,$J,358.3,2785,1,3,0)
 ;;=3^RBC Deglycerolized
 ;;^UTILITY(U,$J,358.3,2786,0)
 ;;=P9040^^30^224^17^^^^1
 ;;^UTILITY(U,$J,358.3,2786,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2786,1,1,0)
 ;;=1^P9040
 ;;^UTILITY(U,$J,358.3,2786,1,3,0)
 ;;=3^RBC Leuko Reduced Irradiated
 ;;^UTILITY(U,$J,358.3,2787,0)
 ;;=P9044^^30^224^3^^^^1
 ;;^UTILITY(U,$J,358.3,2787,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2787,1,1,0)
 ;;=1^P9044
 ;;^UTILITY(U,$J,358.3,2787,1,3,0)
 ;;=3^Cryoprecip Reduced Plasma
 ;;^UTILITY(U,$J,358.3,2788,0)
 ;;=P9051^^30^224^1^^^^1
 ;;^UTILITY(U,$J,358.3,2788,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2788,1,1,0)
 ;;=1^P9051
 ;;^UTILITY(U,$J,358.3,2788,1,3,0)
 ;;=3^Blood,L/R,CMV-Neg
 ;;^UTILITY(U,$J,358.3,2789,0)
 ;;=P9052^^30^224^11^^^^1
 ;;^UTILITY(U,$J,358.3,2789,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2789,1,1,0)
 ;;=1^P9052
 ;;^UTILITY(U,$J,358.3,2789,1,3,0)
 ;;=3^Platelets,HLA-M,L/R,Ea Unit
 ;;^UTILITY(U,$J,358.3,2790,0)
 ;;=P9053^^30^224^14^^^^1
 ;;^UTILITY(U,$J,358.3,2790,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2790,1,1,0)
 ;;=1^P9053
 ;;^UTILITY(U,$J,358.3,2790,1,3,0)
 ;;=3^Plt,Pher,L/R CMV-Neg,Irr
 ;;^UTILITY(U,$J,358.3,2791,0)
 ;;=P9054^^30^224^2^^^^1
 ;;^UTILITY(U,$J,358.3,2791,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2791,1,1,0)
 ;;=1^P9054
 ;;^UTILITY(U,$J,358.3,2791,1,3,0)
 ;;=3^Blood,L/R,Froz/Degly/Wash
 ;;^UTILITY(U,$J,358.3,2792,0)
 ;;=P9055^^30^224^13^^^^1
 ;;^UTILITY(U,$J,358.3,2792,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2792,1,1,0)
 ;;=1^P9055
 ;;^UTILITY(U,$J,358.3,2792,1,3,0)
 ;;=3^Plt,Aph/Pher,L/R,CMV-Neg
 ;;^UTILITY(U,$J,358.3,2793,0)
 ;;=P9058^^30^224^19^^^^1
 ;;^UTILITY(U,$J,358.3,2793,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2793,1,1,0)
 ;;=1^P9058
 ;;^UTILITY(U,$J,358.3,2793,1,3,0)
 ;;=3^RBC,L/R,CMV-Neg,Irrad
 ;;^UTILITY(U,$J,358.3,2794,0)
 ;;=P9059^^30^224^7^^^^1
 ;;^UTILITY(U,$J,358.3,2794,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2794,1,1,0)
 ;;=1^P9059
 ;;^UTILITY(U,$J,358.3,2794,1,3,0)
 ;;=3^Plasma,Frz Between 8-24hrs
 ;;^UTILITY(U,$J,358.3,2795,0)
 ;;=38220^^30^225^1^^^^1
 ;;^UTILITY(U,$J,358.3,2795,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2795,1,1,0)
 ;;=1^38220
 ;;^UTILITY(U,$J,358.3,2795,1,3,0)
 ;;=3^BONE MARROW ASPIRATION
 ;;^UTILITY(U,$J,358.3,2796,0)
 ;;=38221^^30^225^2^^^^1
 ;;^UTILITY(U,$J,358.3,2796,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2796,1,1,0)
 ;;=1^38221
 ;;^UTILITY(U,$J,358.3,2796,1,3,0)
 ;;=3^BONE MARROW BIOPSY
 ;;^UTILITY(U,$J,358.3,2797,0)
 ;;=19000^^30^225^3^^^^1
 ;;^UTILITY(U,$J,358.3,2797,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2797,1,1,0)
 ;;=1^19000
 ;;^UTILITY(U,$J,358.3,2797,1,3,0)
 ;;=3^BREAST CYST ASPIRATION
 ;;^UTILITY(U,$J,358.3,2798,0)
 ;;=19100^^30^225^4^^^^1
 ;;^UTILITY(U,$J,358.3,2798,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2798,1,1,0)
 ;;=1^19100
 ;;^UTILITY(U,$J,358.3,2798,1,3,0)
 ;;=3^BREAST NEEDLE BIOPSY
 ;;^UTILITY(U,$J,358.3,2799,0)
 ;;=10022^^30^225^5^^^^1
 ;;^UTILITY(U,$J,358.3,2799,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2799,1,1,0)
 ;;=1^10022
 ;;^UTILITY(U,$J,358.3,2799,1,3,0)
 ;;=3^FNA W/IMAGE
 ;;^UTILITY(U,$J,358.3,2800,0)
 ;;=10021^^30^225^6^^^^1
 ;;^UTILITY(U,$J,358.3,2800,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2800,1,1,0)
 ;;=1^10021
 ;;^UTILITY(U,$J,358.3,2800,1,3,0)
 ;;=3^FNA W/O IMAGE
 ;;^UTILITY(U,$J,358.3,2801,0)
 ;;=49082^^30^225^7^^^^1
 ;;^UTILITY(U,$J,358.3,2801,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2801,1,1,0)
 ;;=1^49082
 ;;^UTILITY(U,$J,358.3,2801,1,3,0)
 ;;=3^PARACENTESIS
 ;;^UTILITY(U,$J,358.3,2802,0)
 ;;=99195^^30^225^8^^^^1
 ;;^UTILITY(U,$J,358.3,2802,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2802,1,1,0)
 ;;=1^99195
 ;;^UTILITY(U,$J,358.3,2802,1,3,0)
 ;;=3^PHLEBOTOMY
 ;;^UTILITY(U,$J,358.3,2803,0)
 ;;=J2060^^30^226^26^^^^1
 ;;^UTILITY(U,$J,358.3,2803,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2803,1,1,0)
 ;;=1^J2060
 ;;^UTILITY(U,$J,358.3,2803,1,3,0)
 ;;=3^Lorazepam 2mg
